PATENT CLAIM ANALYSIS

Application Number: 16087861
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "210210"]

Abstract:
Disclosed is a new indole compound, in particular, the compound as shown in formula (I), and a preparation method, pharmaceutical composition and use thereof as an estrogen receptor down-regulator in preparing drugs for treating estrogen receptor-positive breast cancer.

Claim (Index 10):
The compound, the pharmaceutically acceptable salt, the hydrate or the prodrug thereof as defined in  claim 9 , wherein, the structural unit is selected from

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16343387', '10465426', '10420399', '11585598', '12245305']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8245451344945168
- 35 USC 102 Novelty (BERT): 0.5542034773779829
- Combined Prediction Score: 0.7975109687828634
- Mean Citation Score: 398.579302
- Max Citation Score: 429.7016
- Similarity Product: 320.7839813494682

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test